Browse by topic.

GLP-1, GIP, glucagon — the incretin and glucagon receptors that anchor modern metabolic peptide pharmacology. A primer on the receptor landscape.

Both are approved metabolic peptide therapeutics. One is a single-receptor agonist, one activates two receptors. Here's what the research actually shows.

A modified amylin analog studied in combination with incretin agonists. Why amylin pharmacology is the underrecognized half of modern metabolic research.

Tirzepatide is the first approved dual GLP-1/GIP receptor agonist. A primer on why dual-incretin pharmacology matters and how the molecule was engineered.

Glycyl-L-histidyl-L-lysine bound to copper(II). Among the most-studied peptide-metal complexes in cosmetic and tissue-research literature.

A 17-amino-acid fragment of one of the most abundant proteins in mammalian cells. Mechanism, half-life, and why it pairs with BPC-157 in tissue-research literature.

A synthetic pentadecapeptide drawn from a sequence in gastric juice. Mechanism, half-life, and why it's one of the most-studied peptides in laboratory tissue-repair research.

A pentapeptide GH-releasing peptide that triggers pulsatile GH release without affecting cortisol or prolactin. The selectivity profile that makes it the canonical reference compound.

A 30-amino-acid peptide for $200 is normal. A 9-amino-acid peptide for $50 is also normal. The pricing logic is more rational than it looks.

The two tests that matter for cell-culture and animal-model work — and why most cosmetic-grade material skips them.

Every legitimate research-peptide supplier publishes a COA per lot. Here's what each section actually means — and which numbers you should trust.

A purity percentage with no chromatogram is roughly worthless. Here's how to read the underlying data and what each peak means.

Lyophilized peptides are stable. Once reconstituted, the clock starts. A practical reference on what to use, what to avoid, and what kills a vial.

From solution-phase to solid-phase to the modern automated synthesizer — how research-peptide manufacturing actually got to the point where you can order a 39-amino-acid molecule for under $200.

Every legitimate research-peptide supplier publishes a COA per lot. Here's what each section actually means — and which numbers you should trust.

A purity percentage with no chromatogram is roughly worthless. Here's how to read the underlying data and what each peak means.

Lyophilized peptides are stable. Once reconstituted, the clock starts. A practical reference on what to use, what to avoid, and what kills a vial.

GLP-1, GIP, glucagon — the incretin and glucagon receptors that anchor modern metabolic peptide pharmacology. A primer on the receptor landscape.

A modified amylin analog studied in combination with incretin agonists. Why amylin pharmacology is the underrecognized half of modern metabolic research.

Glycyl-L-histidyl-L-lysine bound to copper(II). Among the most-studied peptide-metal complexes in cosmetic and tissue-research literature.

A pentapeptide GH-releasing peptide that triggers pulsatile GH release without affecting cortisol or prolactin. The selectivity profile that makes it the canonical reference compound.

A 17-amino-acid fragment of one of the most abundant proteins in mammalian cells. Mechanism, half-life, and why it pairs with BPC-157 in tissue-research literature.

Tirzepatide is the first approved dual GLP-1/GIP receptor agonist. A primer on why dual-incretin pharmacology matters and how the molecule was engineered.

A synthetic pentadecapeptide drawn from a sequence in gastric juice. Mechanism, half-life, and why it's one of the most-studied peptides in laboratory tissue-repair research.